Real Estate
China fund beats 97% of peers by buying Pop Mart, dumping Moutai
[HONG KONG] A 30-year-old Chinese fund manager is trouncing peers this year with a portfolio stocked with Gen Z-favoured names such as Pop Mart International Group, betting that new-age...
China fund beats 97% of peers by buying Pop Mart, dumping Moutai
[HONG KONG] A 30-year-old Chinese fund manager is trouncing peers this year with a portfolio stocked with Gen Z-favoured names such as Pop Mart International Group, betting that new-age...
Australia cuts commodity export outlook despite gold price gain
Earnings from thermal coal will also decline, while its steelmaking counterpart will hold steadyPublished Mon, Jun 30, 2025 · 06:30 AM[MELBOURNE] Australia cut its forecast earnings from commodity exports,...
Nvidia insiders sell over US$1 billion in stock amid market surge
The chipmaker’s stock hit a record on Jun 25, and it reclaimed the crown as the world’s most valuable companyPublished Sun, Jun 29, 2025 · 04:08 PMNVIDIA insiders sold...
Reits and tech lead net institutional inflows; Frencken chair and DHLT CEO raise their stakes
[SINGAPORE] Over the five trading sessions from Jun 20 to 26, institutions remained net sellers of Singapore stocks, with net institutional outflow of S$248 million following the S$74 million...
Best performing S-Reits post double-digit total returns in H1
[SINGAPORE] The S-Reit sector delivered a stable performance in the first half of 2025, with the iEdge S-Reit index gaining 0.6 per cent to 1,010.73 as at Thursday (Jun...
OpenAI turns to Google’s AI chips to power its products: source
Published Sun, Jun 29, 2025 · 08:00 AM[SAN FRANCISCO] OpenAI recently began renting Google’s artificial intelligence (AI) chips to power ChatGPT and its other products, a source close to...
Hong Kong-listed China Medical System seeks secondary listing on SGX
[SINGAPORE] Hong Kong-listed China Medical System (CMS) is seeking a secondary listing on the mainboard of the Singapore Exchange (SGX) in July this year.CMS is a specialty pharma with...
